netFormulary
 Report : A-Z NHS England items in Formulary 25/01/2021 21:14:46
[Back]
 
Section Status NHS England Name
05.03.01 Formulary MHS England Abacavir 
05.03.01 Formulary MHS England Abacavir/lamivudine Kivexa®
05.03.01 Formulary MHS England Abacavir/lamivudine/zidovudine Tizivir®
08.02.04 Formulary MHS England Alemtuzumab 
10.02 Formulary MHS England Ataluren Translarna®
05.03.01 Formulary MHS England Atazanavir 
05.03.01 Formulary MHS England Atazanavir sulfate/cobicistat Evotaz®
08.01.05 Formulary MHS England Avelumab Bavencio®
05.01.09 Formulary MHS England Bedaquiline Sirturo®
05.03.01 Restricted Use MHS England Bictegravir / emtricitabine / tenofovir-alafenamide Biktarvy ®
09.08.01 Formulary MHS England Burosumab Crysvita®
03.04.03 Formulary MHS England C1 esterase inhibitor Cinryze®
03.04.03 Formulary MHS England C1 esterase inhibitor Berinert®
04.08.01 Formulary MHS England Cannabidiol Epidyolex®
10.02 Formulary MHS England Cladribine Mavenclad®
05.03.01 Formulary MHS England Cobicistat Tybost®
03.04.03 Formulary MHS England Conestat alfa Ruconest®
05.03.01 Formulary MHS England Darunavir 
05.03.01 Formulary MHS England Darunavir/cobicistat Rezolsta®
05.03.01 Formulary MHS England Darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate  Symtuza®
05.01.09 Formulary MHS England Delamanid Deltyba®
08.01 Formulary MHS England Dexrazoxane Cardioxane®
05.03.01 Formulary MHS England Didanosine 
05.03.01 Formulary MHS England Dolutegravir 
13.05.03 Formulary MHS England Dupilumab Dupixent®) (dermatology
05.03.01 Formulary MHS England Efavirenz 
05.03.01 Formulary MHS England Efavirenz/emtricitabine/tenofovir disoproxil fumarate  Atripla®
09.01 Restricted Use MHS England Efmoroctocog alfa Elocta®
03.07 Restricted Use MHS England Elexacaftor/tezacaftor/ivacaftor Kaftrio®
05.03.01 Formulary MHS England Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide fumarate  Genvoya®
05.03.01 Formulary MHS England Elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate Stribild®
05.03.01 Formulary MHS England Emtricitabine 
05.03.01 Formulary MHS England Emtricitabine/rilpivirine/tenofovir alafenamide fumarate Odefsey®
05.03.01 Formulary MHS England Emtricitabine/rilpivirine/tenofovir disoproxil fumarate Eviplera®
05.03.01 Formulary MHS England Emtricitabine/tenofovir alafenamide fumarate Descovy®
05.03.01 Formulary MHS England Emtricitabine/tenofovir disoproxil fumarate 
05.03.01 Formulary MHS England Etravirine 
05.03.01 Formulary MHS England Fosamprenavir 
03.04.03 Formulary MHS England Icatibant Firazyr®
09.08.01 Formulary MHS England Inotersen Tegsedi®
05.02.01 Formulary MHS England Isavuconazole Cresemba®
03.07 Restricted Use MHS England Ivacaftor Kalydeco®
05.03.01 Formulary MHS England Lamivudine 
05.03.01 Formulary MHS England Lamivudine/abacavir/dolutegravir Triumeq®
05.01.12 Formulary MHS England Levofloxacin Quinsair®
05.03.01 Formulary MHS England Lopinavir/ritonavir Kaletra®
03.07 Restricted Use MHS England Lumacaftor/ivacaftor Orkambi®
05.03.01 Formulary MHS England Maraviroc Celsentri®
10.02.02 Formulary MHS England Mexiletine Namuscla®
05.03.01 Formulary MHS England Nevirapine 
10.02 Formulary MHS England Nusinersen Spinraza ®
05.03.01 Formulary MHS England Raltegravir 
05.03 Formulary MHS England Remdesivir Veklury®
05.03.01 Formulary MHS England Rilpivirine hydrochloride 
10.02 Formulary MHS England Risdiplam 
05.03.01 Formulary MHS England Ritonavir 
10.01.03 Formulary MHS England Rituximab/rituximab biosimilar MabThera®, Rixathon®, Truxima®) (Rheumatology & Other
02.11 Formulary MHS England Rurioctocog alfa pegol Adynovi®
05.03.01 Formulary MHS England Saquinavir 
05.03.01 Formulary MHS England Stavudine 
02.14 Formulary MHS England Tafamidis Vyndaqel
08.01.05 Formulary MHS England Temozolomide 
05.03.01 Formulary MHS England Tenofovir disoproxil fumarate 
03.07 Restricted Use MHS England Tezacaftor/ivacaftor Symkevi®
09.08.01 Formulary MHS England Trientine  
02.11 Formulary MHS England Turoctocog alfa pegol Esperoct®
09.01 Non Formulary MHS England Vonicog alfa Veyvondi ®
05.03.01 Formulary MHS England Zidovudine 
05.03.01 Formulary MHS England Zidovudine/lamivudine 
Southampton Joint Formulary